Robust evidence has shown that NLRP3 inflammasome activation in liver macrophages leads to hepatocyte death and lack of NLRP3 inflammasome attenuates inflammation and fibrosis in NASH [226,227]. Here, NLRP3 is linked to metabolic dysfunction-associated steatohepatitis.